Skip to content

A national multicenter prospective cohort of breast cancer patients with breast hypertrophy and/or moderate-to-severe breast ptosis undergoing bilateral reduction mammaplasty surgery vs breast conserving surgery

A national multicenter prospective cohort of breast cancer patients with breast hypertrophy and/or moderate-to-severe breast ptosis undergoing bilateral reduction mammaplasty surgery vs breast conserving surgery

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100048187
Enrollment
Unknown
Registered
2021-07-04
Start date
2021-07-15
Completion date
Unknown
Last updated
2022-03-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer

Interventions

Two groups:bilateral reduction mammaplasty surgery vs breast conserving surgery

Sponsors

The West China Clinical Medical College, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1.Diagnosed as early breast cancer patients; 2.No serious combined diseases, and no obvious abnormal function of important organs; 3.Tumor location: The tumor is located in the peripheral quadrant, ?The distance between the tumor and the areola is >= 2cm; 4.Ensure the completion of postoperative radiotherapy; 5.No anti-criteria; 6.Breast hypertrophy and/or moderate-to-severe?breast ptosis, it is recommended to perform breast conserving surgery or bilateral reduction mammaplasty surgery; 7.Able and willing to sign an informed consent.

Exclusion criteria

Exclusion criteria: 1. Radiotherapy during pregnancy; 2. Difficult to reach negative edge,can not guarantee pathological resection negative after reresection; 3. Diffuse distribution; 4. Inflammatory breast cancer; 5. Multicenter lesions, early breast cancer with contraindications to radiotherapy or unwilling to radiotherapy.

Design outcomes

Primary

MeasureTime frame
Breast Cancer Patient-Reported Outcomes Scale ;Incidence of Complications;Life Quality;

Secondary

MeasureTime frame
Economic Costs;

Countries

China

Contacts

Public ContactDu Zhenggui

The West China Clinical Medical College, Sichuan University

docduzg@163.com+86 13880768222

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026